Categories: CoronavirusWorld News

UK Approves Astrazeneca/Oxford COVID-19 Vaccine

 

A coronavirus vaccine developed by drug firm AstraZeneca and Oxford University has been approved for use in Britain, the government said Wednesday, adding the mass rollout will start on January 4.

The vaccine can be stored, transported and handled at normal refrigerated conditions, and is therefore cheaper and easier to administer than the Pfizer/BioNTech and Moderna jabs that require freezing.

Britain will become the first nation to roll out the jab on January 4, Health Secretary Matt Hancock said, amid mounting concerns that another dangerous spike in infections threatens to overwhelm the NHS.

“Brilliant to end 2020 with such a moment of hope,” tweeted Hancock.

“The #coronavirus vaccine is our way out of the pandemic — now we need to hold our nerve while we get through this together.”

The government said in a statement earlier that it had “today accepted the recommendation from the Medicines and Healthcare products Regulatory Agency (MHRA) to authorise Oxford University/AstraZeneca’s COVID-19 vaccine for use.

“This follows rigorous clinical trials and a thorough analysis of the data by experts at the MHRA, which has concluded that the vaccine has met its strict standards of safety, quality and effectiveness,” said the Department of Health and Social Care spokesman.

On Sunday, AstraZeneca’s Chief Executive Pascal Soriot said the vaccine provides “100 percent protection” against severe COVID disease requiring hospitalisation.

He predicted trials would show his firm had achieved a vaccine efficacy equal to Pfizer-BioNTech at 95 per cent and Moderna at 94.5 per cent.

Earlier trials had shown varying outcomes in the AstraZeneca shot’s efficacy.

The vaccine intially showed an average 70 per cent effectiveness but that level jumped to 90 per cent depending on the dosage regime.

Behind this average figure from large-scale trials in the UK and Brazil was a 62 percent effectiveness for those who were vaccinated with two full doses of the shot.

For volunteers who received a half-dose first and then a full dose one month later, however, the vaccine was found to have 90 per cent efficacy.

Rejoice Ewodage

Disqus Comments Loading...
Share
Published by
Rejoice Ewodage

Recent Posts

Gov Sani Offers Free Education To Rescued Kuriga Students

The governor also promised to rebuild the primary and government secondary school kuriga, in addition…

1 second ago

Alleged Certificate Forgery: Court Grants Senator Friday Benson N50m Bail

In addition, the lawmaker must provide two sureties with landed properties in the Federal Capital…

50 mins ago

Alleged Tax Evasion: FG To Arraign Binance, Two Others On April 4

The Federal Government accused Binance of neglecting to register with FIRS for tax purposes and…

52 mins ago

FAAN Shuts KFC Lagos Airport Outlet

FAAN directed KFC to apologise to the affected passenger without further delay.

55 mins ago

Six Enugu Lawmakers Dump LP For PDP

Those who defected are Ejike Eze, (Igbo-Eze North 1);  Johnson Ugwu (Enugu North) Princess Ugwu…

1 hour ago

LP’s BoT Takes Over Party, Insists Abure’s Tenure Has Expired

The LP and the NLC have been at loggerheads recently, with the latter accusing the…

2 hours ago